Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

Vertex Pharmaceuticals expects another year of rapid growth in 2025, after achieving this in the fourth quarter and ...

The Roivant subsidiary Kinevant is to discontinue further development of namilumab for the treatment of sarcoidosis.

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

META_DESC_INVESTMENT_IDEA ...

OrganiGram Holdings Inc (TSX:OGI). reported a significant improvement in its financial performance for the third quarter of fiscal year 2024, with a 25% year-over-year increase in net revenue. The ...

U.S. Marketscategory Traders now see just one Fed rate cut this year February 7, 2025 U.S. Marketscategory US consumer sentiment drops as inflation expectations surge February 7, 2025 U.S ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...